[1]田季雨.PET在帕金森病病理机制研究中的应用近况[J].国际放射医学核医学杂志,2003,27(2):53-55.
　TIAN Ji-yu.Recent application of PET in the pathological mechanisms of PD[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):53-55.
点击复制

PET在帕金森病病理机制研究中的应用近况(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
27
期数:
2003年第2期
页码:
53-55
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Recent application of PET in the pathological mechanisms of PD
作者:
田季雨
720032 西安, 第四军医大学西京医院中医药研究中心
Author(s):
TIAN Ji-yu
Department of Traditional Chinese Medicine in Xi-jing Hospital of The Forth Millitary Medical University, Xi’an 710032, China
关键词:
正电子发射体层显像; 帕金森病; 病理机制
Keywords:
positron emission tomography; Parkinson disease; pathological mechanisms
分类号:
R817.4
摘要:
PET是目前研究分子水平人体医学的最佳手段,PET检查在PD(帕金森病)的发病机制、早期诊断、鉴别诊断及治疗中发挥着重要的作用。尤其为PD的早期诊断提供了更科学的手段,为PD的治愈提供了条件。
Abstract:
PET is the best method in the investigation of molecular pathology at present. In this review, the value of positron emission computed tomography for providing insight into the role of pathology mechanism, early diagnosis, differential diagnosis, mechanisms of motor fluctuations in Parkinson disease is reviewed. Especially it can be used for the early diagnosis of PD, thus being benefitial to the therapy of it.

参考文献/References:

[1] Clicchetti F, Brownell AL, Williams K, et al. Neuroinflam-mation of the nigrostriatal pathway during progressive 6-O-HDA dopamine degeneration in rats monitored by immuno-histochemistry and PET imaging[J]. Eur J Neurosci, 2002, 15(6):991-998.
[2] Rinne JO, Portin R, Ruottinen H, et al. Cognitive impairment and the brain dopaminergic system in Parkinson’s dis-ease:[18F]fluorodopa positron emission tomographic study[J].Arch Neurol, 2000, 57(4):470-475.
[3] Ouchi Y, Kanno T, Okada H, et al. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson’s disease[J]. Brain, 2001, 124(4):784-792.
[4] Sossi V, De-La-Fuente-Fernandez R, Holden JE, et al. Increase in dopamine turnover occurs early in Parkinson’s disease:evidence from a new modeling approach to PET 18F-fluorodopa data[J]. J Cereb Blood Flow Metab, 2002,22(2):232-239.
[5] Moeller JR, Eidelberg D. Divergent expression of regional metabolic topographies in Parkinson’s disease and normal ageing[J]. Brain,1997,120(12):2197-2206.
[6] Antonini A, Leenders KL, Vontobel P, et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson’s disease[J]. Brain, 1997, 120(12):2187-2195.
[7] Ghaemi M, Rudolf J, Schmulling S,et al. FDG-and Dopa-PET in postencephalitic parkinsonism[J]. J Neural Transm, 2000,107(11):1289-1295.
[8] De-la-Fuente-Fernandez R, Lu JQ, Sossi V, et al. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson’s disease:PET evidence of increased dopamine turnover[J]. Ann Neurol, 2001,49(3):298-303.
[9] Guttman M, Stewart D, Hussey D, et al. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD[J]. Neurology, 2001, 56(11):1559-1564.
[10] Brooks DJ. PET studies and motor complications in Parkinson’s disease[J]. Trends Neurosci, 2000, 23(10 Suppl):S101-S108.
[11] De-la-Fuente-Fernandez R, Pal PK, Vingerhoets FJ, et al. Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations[J]. J Neural Transm, 2000, 107(1):49-57.
[12] Ghaemi M, Rudolf J, Hilker R, et al. Increased pineal 18F-dopa uptake is related to severity of Parkinson’s disease-a PET study[J]. J Pineal Res, 2001, 30(4):213-219.
[13] Kassubek J, Juengling FD, Hellwig B, et al. Hypermetabolism in the ventrolateral thalamus in unilateral Parkinsonian resting tremor:a positron emission tomography study[J]. Neurosci Lett, 2001, 304(1-2):17-20.
[14] Nurmi E, Ruottinen HM, Bergman J, et al. Rate of progression in Parkinson’s disease:a 6-[18F] fluoro-L-dopa PET study[J]. Mov Disord, 2001, 16(4):608-615.
[15] Samuel M, Ceballos-Baumann AO, Boecker H, et al. Motor imagery in normal subjects and Parkinson’s disease patients:an H215O PET study[J]. Neuroreport, 2001,12(4):821-828.
[16] Wu JC, Iacono R, Ayman M, et al. Correlation of intellectual impairment in Parkinson’s disease with FDG PET scan[J]. Neuroreport, 2000, 11(10):2139-2144.

相似文献/References:

[1]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
　Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[2]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
　Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[3]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
　ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):1.
[4]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):10.
[5]闫卫红.Raclopride在帕金森病PET中的应用[J].国际放射医学核医学杂志,2005,29(1):27.
　YAN Wei-hong.Application of raclopride PET in Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):27.
[6]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
　DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):148.
[7]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):197.
[8]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):201.
[9]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):205.
[10]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):209.
[11]董爱生,田建明.PET、SPECT及MRS在帕金森病诊断中的应用[J].国际放射医学核医学杂志,2005,29(6):244.
　DONG Ai-sheng,TIAN Jian-ming.The application of PET、SPECT and MRS in Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):244.
[12]谭海波,刘兴党.PET在神经干细胞移植治疗帕金森病研究中的进展[J].国际放射医学核医学杂志,2004,28(6):253.
　TAN Hai-bo,LIU Xing-dang.Progress of PET imaging in the study of neural stem cell transplantation treating Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(2):253.

备注/Memo

备注/Memo:
收稿日期:2002-05-27。
作者简介:田季雨(1971-),男,主治医师,硕士研究生,主要研究方向:中医药治疗帕金森病。
更新日期/Last Update: 1900-01-01